Diana Hausman

2012 - Oncothyreon

In 2012, Diana Hausman earned a total compensation of $596K as Chief Medical Officer at Oncothyreon, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$82,410
Option Awards$168,000
Salary$335,000
Other$10,542
Total$595,952

Hausman received $335K in salary, accounting for 56% of the total pay in 2012.

Hausman also received $82.4K in non-equity incentive plan, $168K in option awards and $10.5K in other compensation.

Rankings

In 2012, Diana Hausman's compensation ranked 8,154th out of 11,487 executives tracked by ExecPay. In other words, Hausman earned more than 29.0% of executives.

ClassificationRankingPercentile
All
8,154
out of 11,487
29th
Division
Services
1,222
out of 1,721
29th
Major group
Engineering, Accounting, Research, Management, And Related Services
108
out of 165
35th
Industry group
Research, Development, And Testing Services
40
out of 56
29th
Industry
Commercial Physical and Biological Research
37
out of 51
28th
Source: SEC filing on April 23, 2015.

Hausman's colleagues

We found four more compensation records of executives who worked with Diana Hausman at Oncothyreon in 2012.

2012

Robert Kirkman

Oncothyreon

Chief Executive Officer

2012

Gary Christianson

Oncothyreon

Chief Operating Officer

2012

Julia Eastland

Oncothyreon

Chief Financial Officer

2012

Scott Peterson

Oncothyreon

Chief Scientific Officer

News

You may also like